Curriculum Vitae

Personal details

Name: Xinping Zhang

Position Title: Professor and Director.

Date of birth：1964.02.27

Contact information：Center for Pharmaceutical Policy Research of School of Health Management，Tongji Medical College, Huazhong University of Science and Technology.

Address: 13 Hangkong Road, Wuhan, Hubei province, 430030, P. R. China

Email: xpzhang602@163.com; Cell Phone: 86-27-8369-2332

Research interests

Key words:

rational medicine use, pharmaceutical policy, hospital management.

Personal statement: 

I have been engaged in the research of rational medicine use, pharmaceutical policy, hospital management and other aspects for many years. I have presided over and undertaken a number of national and provincial research projects which are innovative and forward-looking. For example, how to promote rational medicine use and improve medical service quality through transparency. The NNFS project “Research of regression model on regulatory transparency of essential medicines utilization in primary health care institutions” (No.71173082) was rated as excellent by the NNFS of China in 2018. And the research on community health service contract system won the science and technology progress award of Hubei province and Wuhan municipal people's government in 2006.

Education background and professional experience:

Educational experience:

1. Visiting Scholar，Harvard University，August-October, 2012

2. PhD，Epidemiology and Health Statistics，School of Medicine and Health Management, Tongji Medical College，Huazhong University of Science and Technology (HUST), China，2001–2004;

3. Master，Epidemiology and Health Statistics，School of Public Health, Former Tongji Medical University, China，

1988–1991;

4. Bachelor，Public Health，Department of Health, Former Wuhan Medical College, China，1981–1986

Professional experience:

1. Professor，School of Medicine and Health Management，Tongji Medical College，HUST, China，2005-now;

2. Associate Professor，School of Medicine and Health Management，Tongji Medical College，HUST, China，2000-2005;

3. Lecturer，Department of Management, Former Tongji Medical University, China，1991-2000;

4. Assistant，School of Public Health, Former Tongji Medical University, China，1986-1988.

Selected publications

Books and Chapters:

1.         张新平, 刘兰茹. 药品管理学. 人民卫生出版社，2013.

2.         张新平，张俊超，黄金星. 基本药物制度监测评价研究. 科学出版社，2012.

3.         张新平，罗五金，何国忠. 中国药品监督管理体制研究. 湖南人民出版社，2006.

4.         张新平. 药品包装管理理论与实务. 中国医药科技出版社. 2006.

5.         张新平，陈连剑. 药事法学. 科学出版社，2004.

6.         张新平，李少丽. 药物政策学. 科学出版社，2003.

Positions and Honors

Research Projects related to Pharmaceutical Policy Research:

* National Natural Science Foundation of China (NNSF); The State Food and Drug Administration (CFDA); Ministry of Health (MOH); Health Department of Hubei Province (HB MOH); The health department of Qinhai Province (QH MOH); Xian-Janssen Pharmaceutical Ltd (XJPL); Chinese Center For Disease Control And Prevention (CCDC); Development Research Center of Rural Economy of Chinese State Council (DRCRE CSC); Chinese Pharmaceutical Association (CPA); Community Health Association of China (CHAC); China Social Insurance Association (CHIA); Wuhan Kangle Pharmaceutical co., LTD (WKPL); Mudanjiang Youbo Pharmaceutical co., LTD (MYPL); 37* As the second person in charge, others is the first person in charge.

Peer-review papers (first author or corresponding author):

Rational medicine use and pharmaceutical policy:

1.         Zhang X, Cui Y, Liu C, Zuo K, Tang Y. Antibiotic Sales in Primary Care in Hubei Province, China: An Analysis of 2012-2017 Procurement Records. Int J Environ Res Public Health. 2019;16(18):3376. Published 2019 Sep 12. doi:10.3390/ijerph16183376

2.         Ye LP, Zhang XP. Visualizing the knowledge structure of medication-adherence research: A bibliometric analysis (1997-2016). International Journal of Health Planning and Management, 2019.

3.         Xiong Y, Cui Y, Zhang X. Pharmaceutical expenditure and total healthcare expenditure in OECD countries and China: bidirectional Granger causality on the basis of health level. Expert Review of Pharmacoeconomics & Outcomes Research. 2019; 1-8

4.         Chen H, Liu C, Liu J, Tang Y, Zhang X. Mixed effects of restriction strategies in antimicrobial stewardship programs on antimicrobial use in 121 tertiary hospitals in China. Expert Review of Pharmacoeconomics & Outcomes.2019;19(4):483-489.

5.         Tang Y, Liu C, Liu J, Zhang X, Zuo K. Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China. PharmacoEconomics. 2018.

6.         Tang Y, Liu C, Zhang Z, Zhang X. Effects of prescription restrictive interventions on antibiotic procurement in primary care settings: a controlled interrupted time series study in China. Cost Effectiveness and Resource Allocation. 2018;16.

7.         Tang Y, Liu C, Zhang X. Performance associated effect variations of public reporting in promoting antibiotic prescribing practice: a cluster randomized-controlled trial in primary healthcare settings. Primary Health Care Research and Development. 2017;18(5):482-91.

8.         Tang Y, Liu C, Zhang X. Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China. Applied Health Economics and Health Policy. 2017;15(1):57-64.

9.         Liu J, Wang L, Liu C, et al. Impact of price deregulation policy on the affordability of essential medicines for women’s health: a panel data analysis[J]. Expert review of pharmacoEconomics & outcomes research, 2017, 17(6): 625-631.

10.     Liu C, Zhang X, Liu C, Ewen M, Zhang Z, Liu G. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China. BMC Health Services Research. 2017 Aug 24;17(1):597.

11.     Liu, C., Zhang, X., Xuan, W., Zhang, X., Jie, W., & Zhong, F. Does public reporting influence antibiotic and injection prescribing to all patients? a cluster-randomized matched-pair trial in china. Medicine (Baltimore), 2016, 95(26), e3965.

12.     Tang Y, Liu C, Zhang X. Public reporting as a prescriptions quality improvement measure in primary care settings in China: variations in effects associated with diagnoses. Scientific Reports. 2016;6.

13.     Du X, Wang D, Wang X, Yang S, Zhang X*: Exploring the transparency mechanism and evaluating the effect of public reporting on prescription: a protocol for a cluster randomized controlled trial. BMC Public Health 2015, 15(1).

14.     Liu C, Zhang X*, Wan J: Public reporting influences antibiotic and injection prescription in primary care: a segmented regression analysis. J Eval Clin Pract 2015:n/a-n/a.

15.     Yang L, Liu C, Ferrier J A, et al. Organizational barriers associated with the implementation of national essential medicines policy: A cross-sectional study of township hospitals in China[J]. Social Science & Medicine. 2015, 145: 201-208.

16.     Wang D, Lai X, Liu C, et al. Influence of supplemental parenteral nutrition approach on nosocomial infection in pediatric intensive care unit of Emergency Department: a retrospective study. Nutrition Journal. 2015, 14(1).

17.     Yang L, Liu C, Wang L, Yin X and Zhang X* Public reporting improves antibiotic prescribing for upper respiratory tract infections in primary care: a matched-pair cluster-randomized trial in China. Health Research Policy and Systems, 2014,12:61.

18.     Zhang X, Wang L, Zhang X*. Application of propensity scores to explore the effect of public reporting of medicine use information on rational drug use in China: a quasi-experimental design. BMC Health Services Research, 2014,12:61.

19.     Wang X, Tang Y, Zhang X*. Effect of Publicly Reporting Performance Data of Medicine Use on Injection Use: A Quasi-Experimental Study. PloS one, 2014, 9(10): e109594.

20.     Tang Y，Zhang X，Yang C，Yang L, Wang H，Zhang X*.  Application of propensity scores to estimate the association between government subsidy and injection use in primary health care institutions in China. BMC Health Services Research. 2013,13:183. doi:10.1186/1472-6963-13-183.

21.     Yang L, Liu C, Ferrier JA, Zhou W, Zhang X*(Zhang Xinping). The impact of the National Essential Medicines Policy on prescribing behaviours in primary care facilities in Hubei province of China. Health Policy and Planning, 2013;28(7):750-760.

22.     Zhang X, Xiong Y, Ye J, Deng Z, Zhang X*(Zhang Xinping). Analysis of government investment in primary healthcare institutions to promote equity during the three-year health reform program in China. BMC Health Serv Res. 2013-01-20 2013; 13:114.

23.     Tian X，Song Y，Zhang X, National Essential Medicines List and policy practice: A case study of China's health care reform, BMC Health Services Research 2012, 12:401.

24.     Xiang X, Yang C, Wang D, Ye J, Zhang X. Effects of China’s National Essential Medicines Policy on the Use of Injection in Primary Health Facilities. J Huazhong Univ Sci Technol, 2012,32(4) :626-629.

25.     Yang C, Yang L, Xiang X, Tang Y, Wang H, Nathan Bobai, Zhang X. Interventions Assessment of Prescription Automatic Screening System in Chinese Hospitals: A Systematic Review. Drug Information Journal. 2012, 46 (6): 669-676.

26.     Yang L, Zhang X*, Liu W and Wang H. Multifactor Analysis on the Income of Primary Health Care Institutions Implementing EMS in Hubei Province, China: A Cross-sectional Study. Journal of Health Management. 2012, 14(3): 259-268.

27.     Wang D, Zhang X* The selection of essential medicines in China: progress and the way forward. Southern Med, 2011, 4(1): 22-28.

28.     Yang H, Dib H H, Zhu M, Zhang X* et al. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Health policy and planning, 2010, 25(3): 219-229.

29.     Zhu M, Dib H H, Zhang X*, et al. The influence of health insurance towards accessing essential medicines: The experience from Shenzhen labor health insurance. Health policy, 2008, 88(2): 371-380.

Hospital management：

30.     Xiong Y, Wang D, Chen H, Wang X, Zhang X. Development and Validation of Online Textual Pediatrician-Parent Communication Instrument Based on the SEGUE Framework. BioMed Research International. 2019; 1-8.  

31.     Liu J, Yin C, Liu C, Tang Y, Zhang X. Modeling a Production Function to Evaluate the Effect of Medical Staffing on Antimicrobial Stewardship Performance in China, 2009–2016: Static and Dynamic Panel Data Analyses. Frontiers in Pharmacology. 2018; 9:775.

32.     Wang X, Du X, Liu C, Zhang X. Does the professional attitude of physicians always affect their professional behaviour? A survey in tertiary hospitals in Nanchang City, China. Australian Health Review. Mar 2018.

33.     Wang D, Liu C, Zhang Z, Ye L, Zhang X. Validation of King's transaction process for healthcare provider-patient communication in pharmaceutical context: One cross-sectional study. Research in social & administrative pharmacy: RSAP. Mar 27 2018.

34.     Wang D, Liu C, Zhang Z, Ye L, Zhang X. Testing a healthcare provider-patient communicative relationship quality model of pharmaceutical care in hospitals. International journal of clinical pharmacy. Mar 31 2018.

35.     Ye L, Zhang X, Lai X. Does Hospital Ownership Influence Hand Hygiene Compliance?J Huazhong Univ Sci Technol,2017.1672-0733.

36.     Liu C, Tang Y, Wang D, Zhang X. The effect of public reporting presentation on patients' decision making: An experimental survey in Yunan Province, China. Medicine (Baltimore). 2017 Jun;96(24):e7203.

37.      Zhong F, Liu C, Zhang X. Guideline adherence for the treatment of advanced schistosomiasis japonica in Hubei, China. Parasitology research, 2014: 1-7.

38.     Zheng X, Zhong F, Zhang X. Doctors’ compliance with national guidelines and clinical pathway on the treatment of tuberculosis inpatients in Hubei, China. Journal of Evaluation in Clinical Practice. 2014, 20 (3):288-293.

39.     Shen Y, Li M, Zhang M*, Li Z, Wang L. Development and Influencing Factors of Compliance Behaviors of Investigators in Clinical Trials. J Huazhong Univ Sci Technol, 2014,34(2) :29-33.

40.     Zhang Q, Zhong F, Wu M, Zhang X*. Efficacy of Jian’ganle versus Hugan Pian, Glucuronolactone and Reduced Glutathione in Prevention of Antituberculosis Drug-induced Liver Injury* J Huazhong Univ Sci Technol, 2014,34(3) :29-34.

41.     Liu Q, Tian X, Tian J, Zhang X*(Zhang Xinping). Evaluation of the effects of comprehensive reform on primary healthcare institutions in Anhui Province. BMC Health Serv Res. 2014-01-20 2014; 14:268.

42.     Zhou W, Dong Y, Lin X, Lu W, Tian X, Zhang X*. Community health service capacity in China: a survey in three municipalities. Journal of Evaluation in Clinical Practice. 2011,19(1):167-172.

43.     Zhu M, Hassan H.Dib, Hu J, Tang S, Zhong T, Ming X, Zhang X*. Knowledge, awareness, behavior (KAB) and control of hypertension among urban elderly in Western China. International Journal of Cardiology.2009, 137 (1): 9–15.

44.     Zhang X*, Wang T. Quantitative analysis on economic contribution of community health service in China. J Huazhong Univ Sci Technolog Med Sci. 2004;24(1):103-106.

45.     Bärnighausen T, Liu Y, Zhang X, Sauerborn R. Willingness to pay for social health insurance among informal sector workers in Wuhan, China: a contingent valuation study. BMC Health Serv Res. 2007, 20;7:114.

Population aging and health：

46.     Ye LP, Zhang XP. Social network types and health among older adults in rural China: the mediating role of social support. International Journal of Environmental Research and Public Health, 2019, 16(3): 410